Agios Pharmaceuticals | AGIO - Trade Creditors


Agios Pharmaceuticals reported $16.34M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
Amgen USD 2.86B 16.65B Jun/2026
Arrowhead Research USD 27.78M 2.97M Jun/2026
Astellas Pharma JPY 192.29B 7.47B Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Bayer EUR 6.59B 496M Mar/2026
Biogen USD 403.9M 45.4M Jun/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Daiichi Sankyo JPY 539.05B 57.81B Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Exelixis USD 24.15M 5.47M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Incyte USD 1.39B 1.16B Jun/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
Merck USD 3.86B 541M Mar/2026
Moderna USD 167M 6M Jun/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Novartis USD 4.26B 64M Jun/2026
Novartis USD 4.32B 134M Mar/2026
Pfizer USD 4.58B 75M Jun/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026